After the latest in a series of successful quarters (with $171.2 million in revenue, up 31 percent year over year), DexCom is queuing up some big product launches. On yesterday’s Q4 earnings call, CEO Kevin Sayer provided more detail about the forthcoming G6 continuous glucose monitor as well as the first products to come out of DexCom’s partnership with Verily.
“In a year of much confusion and...
Sharecare has hired two new executives with impressive credentials: John Solomon, who formerly served as vice president of enterprise and government at Apple, will join the company in a strategic advisory role and Dale Rayman, a 27-year Towers Watson vet who also served as chief actuary at Zipongo, will join Sharecare as SVP of actuarial consulting and business development.
“John’s proven...
This week in Paris, companies in the diabetes managment space came together at the Advanced Technologies and Treatments for Diabetes conference to share news and, mostly, a lot of efficacy data. It's an exciting time for the space as closed-loop systems that allow people with diabetes to monitor their glucose continuously and automatically manage their insulin dosing get closer and closer to...
More than two years ago, when Apple first added a list of diabetes management apps to its app store, we covered the list of 13 top picks. A lot can change in a few years, however. And while a few of those same apps still appear on Apple’s current list of 12 diabetes management apps, there’s plenty of new names — though not all new to MobiHealthNews readers — as well.
Read on for Apple’s current...
The National Institute of Diabetes and Digestive and Kidney Diseases, a part of the National Institutes of Health, has given out $41 milion in grants to four studies that will hopefully make the artificial pancreas – a long-sought, fully automated, closed-loop system for insulin regulation – a reality. Two of the studies are underway and two more are slotted to begin recruiting in the next two...
The Centers for Medicare and Medicaid Services has deemed certain therapeutic continuous blood glucose meters (CGMs) as durable medical equipment and thus are eligible for coverage.
It’s not all cut and dry, of course. Eligible devices must fit several definitions: they must be a class III, FDA-approved device, and they must be CGMs that measure blood glucose levels periodically by using sensors...
When it comes to regulating medical devices, the status quo of relying on premarket evidence has its limitations: it’s expensive, it’s time-consuming, and it isn’t necessarily the best data to show how something truly operates in everyday life. But, according to a panel at the Connected Health conference in Washington, D.C, digital health tools that generate a trove of data could put us on...
EHR vendor Cerner has tapped telehealth provider American Well to deliver its virtual health care offerings. Through the partnership, American Well’s platform will integrate with Cerner’s EHR and be made available to all current and future Cerner and American Well clients. Patients will access the virtual care offering through Cerner’s HealtheLife patient engagement portal, which also provides...
A new clinical trial to investigate the use of artificial pancreas system is set to begin, bringing in touchscreen insulin pump maker Tandem Diabetes Care; Dexcom, which makes continuous glucose monitor; and digital, personalized medicine company TypeZero Technologies.
The International Diabetes Closed Loop trial, funded by a grant from the National Institutes of Health to the University of...
Common Sensing, a Cambridge-based company developing a smart connected insulin pen cap, announced that it will test its device in a clinical trial in collaboration with Joslin Diabetes Center, Sanofi, and Dexcom.
The study of 125 subjects will be conducted by Joslin and funded by Sanofi. Patients will be given a Gocap from Common Sensing, a cap that fits on to a disposable insulin pen and can...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
